Free Trial

Hepion Pharmaceuticals (HEPA) SEC Filings & 10K Form

Hepion Pharmaceuticals logo
$0.17 -0.02 (-9.04%)
Closing price 02/21/2025 03:59 PM Eastern
Extended Trading
$0.17 0.00 (-2.34%)
As of 02/21/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Hepion Pharmaceuticals SEC Filings

DateFilerForm TypeView
02/07/2025
8:39 AM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form ARS
02/07/2025
8:50 AM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form ARS/A
02/07/2025
8:53 AM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form DEF 14A
01/27/2025
3:31 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form PRE 14A
01/24/2025
7:32 PM
BIGGER CAPITAL FUND L P (Filed by)
Hepion Pharmaceuticals, Inc. (Subject)
Hepion Pharmaceuticals (Subject)
Form SCHEDULE 13G
01/23/2025
5:03 AM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 424B4
01/21/2025
11:15 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form EFFECT
01/21/2025
8:56 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form S-1MEF
01/15/2025
3:15 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2025
8:19 AM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form S-1/A
01/13/2025
6:00 AM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 10-K/A
12/26/2024
4:22 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/11/2024
7:26 AM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2024
7:48 AM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form DEFA14A
12/02/2024
7:53 AM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form DEFA14A
11/21/2024
4:00 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2024
4:01 PM
Hepion Pharmaceuticals, Inc. (Subject)
Hepion Pharmaceuticals (Subject)
Form 425
11/14/2024
3:52 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/05/2024
5:36 AM
Hepion Pharmaceuticals, Inc. (Subject)
Hepion Pharmaceuticals (Subject)
Form 425
09/05/2024
5:15 AM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
8:04 AM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
8:08 AM
Hepion Pharmaceuticals, Inc. (Subject)
Hepion Pharmaceuticals (Subject)
Form 425
07/22/2024
7:33 AM
Hepion Pharmaceuticals, Inc. (Subject)
Hepion Pharmaceuticals (Subject)
Form 425
07/22/2024
7:28 AM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/15/2024
11:15 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form EFFECT
07/15/2024
4:17 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 424B3
07/11/2024
8:46 AM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
06/24/2024
6:07 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 10-K/A
05/21/2024
4:08 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2024
3:46 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form NT 10-Q
04/16/2024
3:53 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/01/2024
3:30 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form NT 10-K
03/06/2024
3:30 PM
Hepion Pharmaceuticals, Inc. (Issuer)
Hepion Pharmaceuticals (Issuer)
Purcell Michael J. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/06/2024
3:15 PM
Hepion Pharmaceuticals, Inc. (Filer)
Hepion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
7:01 PM
BRANCACCIO JOHN P (Reporting)
Hepion Pharmaceuticals, Inc. (Issuer)
Hepion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
7:01 PM
Hepion Pharmaceuticals, Inc. (Issuer)
Hepion Pharmaceuticals (Issuer)
Lbiati Kaouthar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
7:01 PM
Hepion Pharmaceuticals, Inc. (Issuer)
Hepion Pharmaceuticals (Issuer)
JACOB GARY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
7:01 PM
Block Timothy M. (Reporting)
Hepion Pharmaceuticals, Inc. (Issuer)
Hepion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:HEPA) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners